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Objective: Sex hormones and reproductive factors may be important for osteoarthritis (OA). The aim of
this study was to describe the associations of parity, use of hormone replacement therapy (HRT) and oral
contraceptives (OCs) with cartilage volume, cartilage defects and radiographic OA in a population-based
sample of older women.
Design: Cross-sectional study of 489 women aged 50e80 years. Parity, use of HRT and OC was assessed by
questionnaire; knee cartilage volume and defects by magnetic resonance imaging and knee joint space
narrowing (JSN) and osteophytes by X-ray.
Results: Parity was associated with a deﬁcit in total knee cartilage volume [adjusted b ¼ 0.69 ml, 95%
conﬁdence interval (CI) 1.34, 0.04]. Increasing parity was associated with decreasing cartilage volume
in both the tibial compartment and total knee (both P trend <0.05). Parity was also associated with
greater cartilage defects in the patella compartment [adjusted odds ratio (OR)¼ 2.87, 95% CI¼ 1.39, 5.93]
but not other sites. There was a consistent but non-signiﬁcant increase in knee JSN (OR¼ 2.78, 95%
CI¼ 0.75, 10.31) and osteophytes (OR¼ 1.69, 95% CI¼ 0.59, 4.82) for parous women. Use of HRT and/or
OC was not associated with cartilage volume, cartilage defects or radiographic change.
Conclusions: Parity (but not use of HRT or OC) is independently associated with lower cartilage volume
primarily in the tibial compartment and higher cartilage defects in the patella compartment in this
population-based sample of older women.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is the most common form of arthritis and
a major contributor to functional impairment and reduced inde-
pendence in older people1e3. Female gender has been identiﬁed as
a consistent risk factor for hand and knee OA4. The mechanism of
gender disparity is unclear; however, it may involve less cartilage
development during childhood, a higher rate of cartilage loss after
menopause and greater worsening of cartilage defects over time5.
In addition, body mass index (BMI) appears to be more strongly
associated with both cartilage defects and tibial bone area in
women5 suggesting they are more susceptible to a raised BMI.
While sex hormones are presumed to explain some of the sex: S. Wei, Menzies Research
ol St (Private bag 23), Hobart,
1-3-62267704.
.
s Research Society International. Pdifferences, there is no consensus on the role of these factors in OA,
with protective effects6, no signiﬁcant effects7,8 and even wors-
ening effects9e11 being reported. Reproductive factors, particularly
parity, may also be important due to alterations in sex hormones
and weight changes during pregnancy and the postpartum
period12,13. However, there have been only limited studies exam-
ining the associations between parity and OA including joint
replacement and these again present conﬂicting results9,14e20. The
association between us of oral contraceptive (OC) and OA has not
been extensively studied6 but the use of OCs appears protective for
bone mass and vertebra deformities in this sample21.
Cartilage loss is the cardinal feature of OA22,23. Radiography is
regarded as the gold standard to assess cartilage loss but this
technique has been criticized as insensitive due to its two-
dimensional nature, measurement error and semi-quantitative
assessment24. Magnetic resonance imaging (MRI) can directly
visualize knee structure including cartilage volume, cartilage
defects and subchondral bone size. However, there have been no








Age (years) 62.3 (7.9) 62.0 (7.2) 0.79
Weight (kg) 71.8 (15.1) 71.6 (13.9) 0.94
Height (cm) 160.8 (6.4) 160.7 (6.0) 0.86
BMI (kg/m2) 27.9 (6.4) 27.8 (5.3) 0.90
Smoked (%) 44 42 0.74
Steps (per day) 1429 (631) 1334 (490) 0.31
Ever used OC (%) 65 79 0.02
Current use of HRT (%) 32 42 0.34
Ever use of HRT (%) 64 62 0.84
Tibial cartilage volume (ml) 4.49 (0.84) 4.22 (0.81) 0.04
Femoral cartilage volume (ml) 7.00 (1.15) 6.82 (1.19) 0.35
Patella cartilage volume (ml) 2.80 (0.70) 2.65 (0.67) 0.15
Total knee cartilage volume (ml) 14.4 (2.22) 13.7 (2.04) 0.04
Tibial bone area (cm2) 29.4 (2.7) 29.1 (2.4) 0.59
Tibial cartilage defects (%) 24 17 0.24
Femoral cartilage defects (%) 28 27 0.90
Patella cartilage defect (%) 27 46 0.01
Any cartilage defects (%) 49 56 0.34
JSN (%) 15 24 0.18
Osteophytes (%) 11 14 0.34
Data presented by mean and SD except where indicated. P values derived from
unequal t test for continuous variables and chi2 or Fisher’s exact for dichotomous
variables. Parous was deﬁned as any live or still birth. JSN and defects deﬁned as
a score 2 and osteophytes deﬁned as a score 1 at any site measured at knees
including both left and right. Bold denote signiﬁcant results.
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estrogen replacement therapy (ERT)25e27. Therefore, the aim of this
cross-sectional study was to describe the associations between
parity, use of hormone replacement therapy (HRT) and OCs and
knee cartilage volume, cartilage defects, and radiographic OA in
a population-based sample of older women.
Materials and methods
Subjects
This study used data from the Tasmanian Older Adult Cohort
(TASOAC) study which is an ongoing prospective study in southern
Tasmania, Australia. Its primary aims were to determine the envi-
ronmental, genetic and biochemical factors associated with the
development and progression of OA and osteoporosis. A total of
1,100 participants aged 50e80 years were randomly selected using
computer-generated random numbers from the roll of electors in
southern Tasmania, a comprehensive population listing, with an
equal number of men andwomen selected. Baseline measurements
were collected from April 2002 to September 2004. Participants
were excluded if theywere institutionalized, had a contraindication
toMRI (includingmetal sutures, presence of shrapnel, iron ﬁlings in
the eye, and claustrophobia). All participants provided written
informed consent and the study was approved by the Southern
Tasmania Health and Medical Human Research Ethics Committee.
The current study refers to women only.
Reproductive factors and other characteristics
Women’s reproductive history was assessed by self-
administered questionnaire. Parity was deﬁned based on the
women’s live or still births and then categorized as follows
(1¼ nulliparous, 2¼ one to two children, 3¼ three to four children,
and 4¼ ﬁve or more) to ensure similar proportions in each group.
Ever use and duration of OC use, current use of HRTand ever use and
duration of use of HRTwere also assessed by questionnaire. Years of
use of OC and HRTwere categorized as less than 5 years and 5 years
or greater. Other reproductive factors included age at menarche,
breastfeeding, menopause, and hysterectomy. The highest educa-
tion level and employment status were assessed by questionnaire.
Physical activity as mean steps per day was assessed by HJ-002
pedometer (Omron, Tokyo, Japan) as previously described28.
Knee pain was assessed by self-administered questionnaire
(WOMAC)29. Five categories ofpain (walkingonﬂat surface, goingup/
down stairs, pain at night, sitting/lying, and standing upright) were
assessed separately with a 10-point scale from 0 (no pain) to 9 (most
severe pain) for each category. A total pain score can range from 0 to
45. A history of knee surgery was assessed by the questionnaire and
deﬁned as a dichotomized variable. Hand OA was assessed by hand
photographs15 and presence of handOAwas deﬁned ifwomenhad at
least one Heberden’s node (NH) in either hand.
Height was measured to the nearest 0.1 cm (with shoes, socks
and headgear removed) using a stadiometer. Weight was measured
to the nearest 0.1 kg (with shoes, socks and bulky clothing
removed) using a single pair of electronic scales (Delta Model 707;
Hamburg, Germany) that was calibrated using a known weight at
the beginning of each clinic. BMI was calculated as the ratio of
weight (kg) to height (m) squared (kg/m2).
MRI measurement
Cartilage volume of the right knee was assessed by MRI. Knees
were imaged in the sagittal plane on a 1.5 T whole-body MR unit
(Picker, Cleveland, OH, USA), and a fat-suppressed T1-weightedspoiled gradient-echo sequence was used. Knee cartilage volume
was determined by means of image processing on an independent
workstation as previously described30,31. Sagittal images were
obtained at a partition thickness of 1.5 mm and an in-plane resolution
of 0.310.31 mm (512 512 pixels). The volume of individual carti-
lage plates (medial tibial, lateral tibial, medial femoral, lateral femoral
and patella) was isolated from the total volume of cartilage by
manually drawing disarticulation contours around the cartilage
boundaries on a section-by-section basis. These data were then
resampled by means of bilinear and cubic interpolation (area of
312 mm 312 mm and 1.5 mm thickness, continuous sections) for the
ﬁnal three-dimensional (3D) rendering. The volume of the particular
cartilage plate was then determined by summing all the pertinent
voxelswithin the resultant binaryvolume. The coefﬁcients of variation
(CV) obtained for cartilage volume measurements were 2.1e2.6%31.
Knee femoral cartilage volumewasdeterminedusingCartiscope
(ArthroVision Inc., Montreal, Canada) running on a Windows NT/9x
workstation, as previously described32e35. Cartilage volume was
evaluated directly from a standardized view of 3D cartilage geometry
as the sum of elementary volumes. The CV was about 2%34.
Cartilage defects on a 0e4 scale were graded at the medial and
lateral tibial, medial and lateral femoral and patella sites as
follows36,37: grade 0¼ normal cartilage; grade 1¼ focal blistering
and intracartilaginous low-signal intensity area with an intact
surface and bottom; grade 2¼ irregularity on the surface or bottom
and loss of thickness of<50%; grade 3¼ deep ulcerationwith loss of
thickness >50%; grade 4¼ full-thickness chondral wear with
exposure of subchondral bone. A cartilagedefect had tobepresent in
at least twoconsecutive slices andwasdeﬁned as a scoreof2 at any
site measured at the knee (within that compartment). Intra-
observer reliability expressed as intraclass correlation coefﬁcient
(ICC)was 0.89e0.94, and inter-observer reliability was 0.85e0.9338.
Tibial bone area was determined at the medial and lateral
compartments as previously described24. To transform the image
from the sagittal to the axial plane, we used the Analyze Software
package developed by the Mayo Clinic (Rochester, MN, USA).
Medial and lateral tibial plateau bone area was determined by
creating an isotropic volume from the three input images closet to
Table II










Parity (yes/no) 1.76 (0.77, 4.07) 2.78 (0.75, 10.31) 1.40 (0.53, 3.68) 1.69 (0.59, 4.82)
Number of children
Nulliparous (n¼ 51) Reference Reference Reference Reference
1e2 (n¼ 194) 1.60 (0.67, 3.84) 2.55 (0.64, 10.08) 1.33 (0.48, 3.68) 1.51 (0.36, 6.27)
3e4 (n¼ 199) 1.68 (0.70, 4.02) 3.02 (0.77, 11.89) 1.31 (0.47, 3.64) 1.81 (0.44, 7.41)
5 (n¼ 45) 3.20 (1.14, 9.02) 2.79 (0.61, 12.77) 2.17 (0.65, 7.27) 1.68 (0.35, 8.10)
P trend 0.05 0.17 0.30 0.47
Ever use of OC (ever/never) 0.48 (0.29, 0.78) 0.69 (0.34, 1.43) 0.51 (0.29, 0.92) 0.88 (0.38, 2.06)
Current use of HRT (current/never) 0.94 (0.52, 1.68) 1.25 (0.65, 2.41) 0.42 (0.20, 0.91) 0.49 (0.22, 1.12)
Ever use of HRT (ever/never) 1.02 (0.64, 1.63) 1.35 (0.81, 2.25) 0.58 (0.34, 1.00) 0.65 (0.36, 1.18)
JSN deﬁned as a score 2 and osteophytes deﬁned as a score 1 at any site measured at knees including both left and right. Bold denote signiﬁcant results.
* Adjusted for age, BMI, smoking, parity, WOMAC-pain score, and use of OC and HRT where appropriate.
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then directly measured from the reformatted axial images. The CV
we obtained for these measurements were 2.2e2.6%.
X-ray measurement
A standing anteroposterior view of the right and left knee in
a ﬁxed semiﬂexed position was performed on all subjects at base-
line and scored individually for osteophytes and joint space nar-
rowing (JSN) on a scale of 0e3 (0¼ normal and 3¼ severe)
according to the Osteoarthritis Research Society International
atlas39 as previously described24. The presence of osteophytes was
deﬁned as any score1 whereas JSNwas deﬁned as any score2 in
the tibiofemoral compartments of either knee.
Statistical analysis
Unequal variance t-test was used to assess differences between
parous and nulliparous for continuous characteristics whereas Chi2
or Fisher’s exact tests were used for categorical variables.
Descriptive characteristics are presented as mean [standard devi-
ation (SD)] or percentage. Cartilage volume was normally distrib-
uted. Univariable and multivariable linear regression analyses were
employed to examine the associations between parity, use of HRT
and/or OC and cartilage volume before and after adjustment for
age, BMI, smoking, WOMAC-pain score and use of OC and/or HRT
where appropriate. Confounders were selected based on our
previous studies which identiﬁed age, BMI and smoking as
important covariates and the observed differences between parous
and nulliparous women in this study. Logistic regression analysesTable III
The associations between parity, HRT, OC, total knee cartilage volume and cartilage defe
Cartilage volume
Unadjusted b (95% CI) A
b
Parity (yes/no) L0.73 (L1.38, L0.08) L
Number of children
Nulliparous (n¼ 51) Reference R
1e2 (n¼ 194) 0.59 (1.28, þ0.10) 
3e4 (n¼ 199) L0.73 (L1.41, L0.04) 
5 (n¼ 45) L1.47 (L2.42, L0.52) L
P trend 0.01
Ever use of OC (ever/never) þ0.17 (0.33, þ0.67) 
Current use of HRT (current/never) þ0.02 (0.50, þ0.53) þ
Ever use of HRT (ever/never) þ0.35 (0.07, þ0.77) þ
b: regression coefﬁcient representing difference in mean cartilage volume (ml). Bold den
* Any cartilage defects deﬁned as a defect score of 2.
y Adjusted for age, BMI, smoking, parity, WOMAC-pain score, and use of OC and HRTwere used to investigate parity, use of HRT and OC, and the asso-
ciations with presence of cartilage defects, JSN and osteophytes. All
statistical analyses were performed on intercooled Stata 9.2 for
windows (Statacorp, Texas, USA).
Results
There were 489 female participants aged 50e80 years (mean
age 62 (7.3) years, mean BMI 27.8 (5.5) kg/m2) who completed
the questionnaires and had had MRI measured in the TASOAC
study. Of these, 454 had a knee radiograph. Participants’ charac-
teristics are outlined in Table I. The majority of womenwere parous
and most women had at some point used OC and/or HRT. Parous
women were more likely to have been OC users, and to have lower
tibial and total knee cartilage volume and a higher prevalence of
patella cartilage defects than nulliparouswomenwith no difference
in the bone size and steps per day. Prevalence of JSN was 15%, 22%,
23% and 36% for each parity group from nulliparous to group 3
(5 children) respectively, whereas the prevalence of osteophytes
for each group was 11%, 14%, 14% and 21%.
The associations between reproductive factors and radiographic
OA are shown in Table II. Parous women had higher odds of both
JSN and osteophytes compared with nulliparous, but none of these
reached statistical signiﬁcance. Use of OC and HRT was not signif-
icantly associated with either JSN or osteophytes after adjustment
for confounders although users of either had generally lower odds
of osteophytes.
The associations between parity and cartilage volume are shown
in Table III. Compared with nulliparous women, parous women had








0.69 (L1.34,L0.04) 1.33 (0.74, 2.37) 1.42 (0.75, 2.71)
eference Reference Reference
0.62 (1.30, þ0.07) 1.48 (0.80, 2.75) 1.61 (0.81, 3.20)
0.68 (1.36, þ0.003) 1.13 (0.61, 2.08) 1.29 (0.65, 2.56)
1.07 (L2.04,L0.09) 1.71 (0.76, 3.87) 1.25 (0.50, 3.14)
0.04 0.75 0.95
0.10 (0.65, þ0.45) 0.67 (0.43, 1.04) 0.98 (0.58, 1.66)
0.03 (0.48, þ0.55) 0.66 (0.41, 1.05) 0.69 (0.42, 1.14)
0.31 (0.11, þ0.73) 0.88 (0.60, 1.29) 0.99 (0.66, 1.49)
ote signiﬁcant results.
where appropriate.
Fig. 1. Compartment speciﬁc cartilage volume by parity. P value adjusted for age, BMI,
smoking, and use of OC and HRT. Group 1¼ nulliparous. Group 2¼ one to two children.
Group 3¼ three to four children. Group 4¼ ﬁve or more children.
Fig. 2. Compartment speciﬁc cartilage defects by parity. P value was adjusted for age,
BMI, smoking and use of OC and HRT.
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association with decreasing cartilage volume in both the tibial
compartment (Fig.1) and total knee (Table III), andwomenwho had
ﬁve or more children had signiﬁcantly lower cartilage volumecompared with nulliparous women. Total cartilage volume
decreased by 0.27 ml (95% CI¼0.52, 0.01) and tibial cartilage
volume by 0.10 ml (95% CI¼0.20, 0.01) for each increasing
parity group. Parity was also associatedwith increased odds of knee
cartilage defects but only at the patella compartment (Fig. 2) which
were signiﬁcantly higher for parous women [adjusted odds ratio
(OR)¼ 2.87, 95% CI¼ 1.39, 5.93].
Use of HRT was generally associated with modestly higher total
knee cartilage volume and lower cartilage defects (Table III) but
none of these differences were signiﬁcant. OC use was not signiﬁ-
cantly associated with either cartilage volume or cartilage defects
(Table III).
Age at menarche, breastfeeding, menopause and history of
hysterectomy, were also assessed but had no association with any
outcome measure (data not shown). The highest education level
was associated positively with cartilage volume (P¼ 0.02) but not
with parity (P¼ 0.99) whereas employment status was associated
with parity (P¼ 0.03) but not cartilage volume (P¼ 0.85). Further
adjustments for these two factors the associations between parity
and cartilage volume were not changed (data not shown).
Knee surgery and WOMAC-pain score were not associated with
parity or cartilage volume though they were both associated with
cartilage defects and radiographic OA. Hand OA was negatively
associated with cartilage volume but not associated with parity,
cartilage defects or radiographic OA. Further adjustment for these
three factors did not change the associations between parity and
cartilage and radiographic OA in this study (data not shown). There
was no association between parity and change in either cartilage
volume or cartilage defects over 2.7 years (data not shown).
Discussion
In this cross-sectional population-based study, parity was
independently associated with a lower cartilage volume in the
tibial compartment and total knee, and higher cartilage defects in
the patella compartment in older women. These results suggest
parity may have an effect on the natural history of knee OA.
No previous studies have examined the associations between
parity and knee cartilage. Studies of parity and the associations
with clinical or radiographic OA or a risk of joint replacement are
limited and have presented conﬂicting results9,14e20. Of the eight
studies we identiﬁed, ﬁve studies showed no association with
radiographic or symptomatic OA14,16,17,19, one study presented
a negative association with hand radiographic OA but not lower
limb18, and two studies reported positive associations with hand
OA or joint replacement9,15. Differing ﬁndings between studies
might be due to differences in the characteristics of study
S. Wei et al. / Osteoarthritis and Cartilage 19 (2011) 1307e1313 1311participants (such as age), deﬁnitions of OA, site measured or the
ability to adjust for confounders. In our study, knee OA was
assessed by radiography with no signiﬁcant associations with
reproductive factors found which is consistent with most of the
above studies. However, MRI measurements had a number of
signiﬁcant associations examining parity as both a dichotomous
variable and as number of children, suggesting radiographic OA is
much less sensitive thanMRI assessment. Therewas some variation
between sites with parity being associated with tibial cartilage
volume and patella cartilage defects. This is largely unexplained.
However, cartilage defects and cartilage volume loss may not
necessarily appear together in the same OA knee compartment as
cartilage defects assess focal lesions whereas cartilage volume
provides a more global evaluation of cartilage loss in an entire
compartment. The association between parity and cartilage defects
could be real as it ﬁts with the overall cartilage volume effect.
However, it could also be a chance association.
We have further examined the follow-up data of cartilage
volume and the defects and found that parity was not associated
with either cartilage volume change or change in cartilage defects.
This might be expected given that pregnancy was an exposure in
the relatively distant past.
The mechanism underlying the association between parity and
cartilage is not clear. There are several possibilities including
alterations in sex hormones, weight gain, loading on the knee
(weight gain and baby carrying) and change in lifestyle which
includes increased household chores or a reduction in recreational
physical activity during the period of pregnancy and breastfeeding.
The levels of both estrogen and progesterone increase during
pregnancy12 and the receptors for both hormones have been found
in human cartilage40,41. Most women gainweight during pregnancy
and a weight gain of 11e15 kg is recommended for normal weight
women (BMI 19.8e26.0 kg/m2) to achieve optimal fetal and
maternal outcomes13. Weight gain may also persist after birth
increasing the load to the knee. While we have adjusted for current
weight, we did not assess weight gain during pregnancy as this
would likely be subject to considerable recall error given the age of
our participants. Women with high parity may have a lower
socioeconomic status withmore household chores thus this may be
another potential mechanism underlying the associations.
However further adjustment for highest education level achieved
and employment status did not change the associations between
parity and cartilage.
There is evidence that ERT may have a protective effect on
radiographic OA in postmenopausal women42,43; however, limited
studies have explored the effect of sex hormones on cartilage. A
cross-sectional study of 81 participants found that users of ERT for
5 or more years had more tibial knee cartilage volume than non-
users25 but this association was not present for patella cartilage
volume26, and a longitudinal analysis of 57 participants from the
same sample found no association between ERT and change in
tibial cartilage volume over 2.5 years of follow-up27. Our study with
a relatively large number of participants is most consistent with
little or no effect of HRT on either MRI or radiographic measure-
ments of cartilage. Similarly, OC use and duration were not asso-
ciated with cartilage health although OC use is associated with
bone mass and vertebral deformity in these women21.
One of the important limitations of this study is that several
factors assessed by questionnaire are subject to recall. However,
responses to questions relating to parity and current use of HRT
would be considered highly accurate. It is likely that, any misclas-
siﬁcation would be no-differential thus would shift our results
toward the null as reproductive history was assessed at the same
time as clinical measurements. We assessed radiographic OA at the
tibiofemoral compartment only therefore we cannot address anyassociation with patellofemoral radiographic OA. We have taken
still birth into account when assessing parity but twins or triplets
were not assessed in this study so may potentially result in
misclassiﬁcation of women by parity group. However the number
of multiple births is likely to be very small and misclassiﬁcation
would likely to result in an underestimation of the association if the
number of pregnancies is over estimated. Another limitation is the
cross-sectional design, which does not allow testing of causal
pathways, although births occurredmany years prior to assessment
of cartilage, and there was a dose response association suggesting
a biologically plausible association.
In conclusion, parity (but not use of HRT or OC) is independently
associated with lower cartilage volume primarily in the tibial
compartment and higher cartilage defects in the patella compart-
ment in this population-based sample of older women.
Author contributions
Conception and design: SW, AV, GJ.
Acquisition of data: SW, JMP, JPP, FA, GJ.
Analysis and interpretation of data: SW, AV, CD, GJ.
Drafting the article or critical revision: SW,AV, CD, JMP, JPP, FV,GJ.
Role of the funding source
The TASOAC study was supported by the National Health and
Medical Research Council of Australia; Arthritis Foundation of
Australia; Tasmanian Community Fund; Masonic Centenary
Medical Research Foundation; Royal Hobart Hospital Research
Foundation; and University of Tasmania Institutional Research
Grants Scheme.
Conﬂict of interest
The authors have no conﬂicts of interest to declare.
Acknowledgments
We especially thank the participants who made this study
possible, and we gratefully acknowledge the role of TASOAC staff
and volunteers in collecting the data, particularly research nurses
Catrina Boon and Pip Boon.
References
1. Cunningham LS, Kelsey JL. Epidemiology of musculoskeletal
impairments and associated disability. Am J Public Health
1984;74:574e9.
2. Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y,
Wilson PW, et al. The effects of speciﬁc medical conditions on
the functional limitations of elders in the Framingham Study.
Am J Public Health 1994;84:351e8.
3. March LM, Brnabic AJ, Skinner JC, Schwarz JM, Finnegan T,
Druce J, et al. Musculoskeletal disability among elderly people
in the community. Med J Aust 1998;168:439e42.
4. Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D,
Jones G, et al. A meta-analysis of sex differences prevalence,
incidence and severity of osteoarthritis. Osteoarthritis
Cartilage 2005;13:769e81.
5. Ding C, Cicuttini F, Jones G. Tibial subchondral bone size and
knee cartilage defects: relevance to knee osteoarthritis.
Osteoarthritis Cartilage 2007;15:479e86.
6. de Klerk BM, Schiphof D, Groeneveld FP, Koes BW, van
Osch GJ, van Meurs JB, et al. Limited evidence for a protective
effect of unopposed oestrogen therapy for osteoarthritis of the
S. Wei et al. / Osteoarthritis and Cartilage 19 (2011) 1307e13131312hip: a systematic review. Rheumatology (Oxford) 2009;48:
104e12.
7. Karlson EW, Mandl LA, Aweh GN, Sangha O, Liang MH,
Grodstein F. Total hip replacement due to osteoarthritis: the
importance of age, obesity, and other modiﬁable risk factors.
Am J Med 2003;114:93e8.
8. Zhang Y, McAlindon TE, Hannan MT, Chaisson CE, Klein R,
Wilson PW, et al. Estrogen replacement therapy and wors-
ening of radiographic knee osteoarthritis: the Framingham
Study. Arthritis Rheum 1998;41:1867e73.
9. Liu B, Balkwill A, Cooper C, Roddam A, Brown A, Beral V, et al.
Reproductive history, hormonal factors and the incidence of
hip and knee replacement for osteoarthritis in middle-aged
women. Ann Rheum Dis 2009;68:1165e70.
10. Sandmark H, Hogstedt C, Lewold S, Vingard E. Osteoarthrosis
of the knee in men and women in association with over-
weight, smoking, and hormone therapy. Ann Rheum Dis 1999;
58:151e5.
11. Von Muhlen D, Morton D, Von Muhlen CA, Barrett-Connor E.
Postmenopausal estrogen and increased risk of clinical osteo-
arthritis at the hip, hand, and knee in older women. J Womens
Health Gend Based Med 2002;11:511e8.
12. Tulchinsky D, Hobel CJ, Yeager E, Marshall JR. Plasma estrone,
estradiol, estriol, progesterone, and 17-hydroxyprogesterone
in human pregnancy. I. Normal pregnancy. Am J Obstet
Gynecol 1972;112:1095e100.
13. Parker JD, Abrams B. Prenatal weight gain advice: an
examination of the recent prenatal weight gain recommen-
dations of the Institute of Medicine. Obstet Gynecol 1992;79:
664e9.
14. Anderson JJ, Felson DT. Factors associated with osteoarthritis
of the knee in the ﬁrst national Health and Nutrition Exami-
nation Survey (HANES I). Evidence for an association with
overweight, race, and physical demands of work. Am J Epi-
demiol 1988;128:179e89.
15. Cooley HM, Stankovich J, Jones G. The association between
hormonal and reproductive factors and hand osteoarthritis.
Maturitas 2003;45:257e65.
16. Dawson J, Juszczak E, Thorogood M, Marks SA, Dodd C,
Fitzpatrick R, et al. An investigation of risk factors for symp-
tomatic osteoarthritis of the knee in women using a life
course approach. J Epidemiol Community Health 2003;57:
823e30.
17. Dennison EM, Arden NK, Kellingray S, Croft P, Coggon D,
Cooper C, et al. Hormone replacement therapy, other repro-
ductive variables and symptomatic hip osteoarthritis in elderly
white women: a case-control study. Br J Rheumatol 1998;37:
1198e202.
18. Samanta A, Jones A, Regan M, Wilson S, Doherty M. Is osteo-
arthritis in women affected by hormonal changes or smoking?
Br J Rheumatol 1993;32:366e70.
19. Tepper S, Hochberg MC. Factors associated with hip osteoar-
thritis: data from the First National Health and Nutrition
Examination Survey (NHANES-I). Am J Epidemiol 1993;137:
1081e8.
20. Caspi D, Flusser G, Farber I, Ribak J, Leibovitz A, Habot B, et al.
Clinical, radiologic, demographic, and occupational aspects of
hand osteoarthritis in the elderly. Semin Arthritis Rheum
2001;30:321e31.
21. Wei S, Venn A, Ding C, Foley S, Laslett L, Jones G. The associ-
ation between oral contraceptive use, bone mineral density
and fractures in women aged 50e80 years. Contraception In
press. doi:10.1016/j.contraception.2011.02.001.
22. Eckstein F, Lemberger B, Gratzke C, Hudelmaier M, Glaser C,
Englmeier KH, et al. In vivo cartilage deformation afterdifferent types of activity and its dependence on physical
training status. Ann Rheum Dis 2005;64:291e5.
23. Cicuttini FM, Wluka AE, Stuckey SL. Tibial and femoral carti-
lage changes in knee osteoarthritis. Ann Rheum Dis 2001;60:
977e80.
24. Jones G, Ding C, Scott F, Glisson M, Cicuttini F. Early radio-
graphic osteoarthritis is associated with substantial changes in
cartilage volume and tibial bone surface area in both males
and females. Osteoarthritis Cartilage 2004;12:169e74.
25. Wluka AE, Davis SR, Bailey M, Stuckey SL, Cicuttini FM. Users
of oestrogen replacement therapy have more knee cartilage
than non-users. Ann Rheum Dis 2001;60:332e6.
26. Cicuttini FM, Wluka AE, Wang Y, Stuckey SL, Davis SR. Effect of
estrogen replacement therapy on patella cartilage in healthy
women. Clin Exp Rheumatol 2003;21:79e82.
27. Wluka AE, Wolfe R, Davis SR, Stuckey S, Cicuttini FM. Tibial
cartilage volume change in healthy postmenopausal women:
a longitudinal study. Ann Rheum Dis 2004;63:444e9.
28. Ding C, Cicuttini F, Boon C, Boon P, Srikanth V, Cooley H, et al.
Knee and hip radiographic osteoarthritis predict total hip bone
loss in older adults: a prospective study. J Bone Miner Res
2010;25:858e65.
29. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW.
Validation study of WOMAC: a health status instrument for
measuring clinically important patient relevant outcomes to
antirheumatic drug therapy in patients with osteoarthritis of
the hip or knee. J Rheumatol 1988;15:1833e40.
30. Cicuttini F, Forbes A, Morris K, Darling S, Bailey M, Stuckey S,
et al. Gender differences in knee cartilage volume as measured
by magnetic resonance imaging. Osteoarthritis Cartilage 1999;
7:265e71.
31. Jones G, Glisson M, Hynes K, Cicuttini F. Sex and site differ-
ences in cartilage development: a possible explanation for
variations in knee osteoarthritis in later life. Arthritis Rheum
2000;43:2543e9.
32. Berthiaume MJ, Raynauld JP, Martel-Pelletier J, Labonte F,
Beaudoin G, Bloch DA, et al. Meniscal tear and extrusion are
strongly associated with progression of symptomatic knee
osteoarthritis as assessed by quantitative magnetic resonance
imaging. Ann Rheum Dis 2005;64:556e63.
33. Raynauld JP, Kauffmann C, Beaudoin G, Berthiaume MJ, de
Guise JA, Bloch DA, et al. Reliability of a quantiﬁcation imaging
system using magnetic resonance images to measure cartilage
thickness and volume in human normal and osteoarthritic
knees. Osteoarthritis Cartilage 2003;11:351e60.
34. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Labonte F,
Beaudoin G, de Guise JA, et al. Quantitative magnetic reso-
nance imaging evaluation of knee osteoarthritis progression
over two years and correlation with clinical symptoms and
radiologic changes. Arthritis Rheum 2004;50:476e87.
35. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Beaudoin G,
Choquette D, Haraoui B, et al. Long term evaluation of disease
progression through the quantitative magnetic resonance
imaging of symptomatic knee osteoarthritis patients: corre-
lation with clinical symptoms and radiographic changes.
Arthritis Res Ther 2006;8:R21.
36. Ding C, Cicuttini F, Scott F, Cooley H, Boon C, Jones G, et al.
Natural history of knee cartilage defects and factors affecting
change. Arch Intern Med 2006;166:651e8.
37. Drape JL, Pessis E, Auleley GR, Chevrot A, Dougados M, Ayral X,
et al. Quantitative MR imaging evaluation of chondropathy in
osteoarthritic knees. Radiology 1998;208:49e55.
38. Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G, et al.
Knee cartilage defects: association with early radiographic
osteoarthritis, decreased cartilage volume, increased joint
S. Wei et al. / Osteoarthritis and Cartilage 19 (2011) 1307e1313 1313surface area and type II collagen breakdown. Osteoarthritis
Cartilage 2005;13:198e205.
39. Buckland-Wright C. Protocols for precise radio-anatomical posi-
tioning of the tibiofemoral and patellofemoral compartments of
the knee. Osteoarthritis Cartilage 1995;3(Suppl A):71e80.
40. Richette P, Corvol M, Bardin T. Estrogens, cartilage, and oste-
oarthritis. Joint Bone Spine 2003;70:257e62.
41. Ben-Hur H, Thole HH, Mashiah A, Insler V, Berman V, Shezen E,
et al. Estrogen, progesterone and testosterone receptors inhuman fetal cartilaginous tissue: immunohistochemical
studies. Calcif Tissue Int 1997;60:520e6.
42. Hanna FS, Wluka AE, Bell RJ, Davis SR, Cicuttini FM. Osteoar-
thritis and the postmenopausal woman: epidemiological,
magnetic resonance imaging, and radiological ﬁndings. Semin
Arthritis Rheum 2004;34:631e6.
43. Silman AJ, Newman J. Obstetric and gynaecological factors in
susceptibility to peripheral joint osteoarthritis. Ann Rheum Dis
1996;55:671e3.
